The Relationship between Body Composition, Fatty Acid Metabolism and Diet in Spinal Muscular Atrophy.

diet fatty acid metabolism nutrition spinal muscular atrophy survival motor neuron

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
20 Jan 2021
Historique:
received: 12 12 2020
revised: 15 01 2021
accepted: 17 01 2021
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 28 1 2021
Statut: epublish

Résumé

Spinal muscular atrophy (SMA) is an autosomal recessive condition that results in pathological deficiency of the survival motor neuron (SMN) protein. SMA most frequently presents itself within the first few months of life and is characterized by progressive muscle weakness. As a neuromuscular condition, it prominently affects spinal cord motor neurons and the skeletal muscle they innervate. However, over the past few decades, the SMA phenotype has expanded to include pathologies outside of the neuromuscular system. The current therapeutic SMA landscape is at a turning point, whereby a holistic multi-systemic approach to the understanding of disease pathophysiology is at the forefront of fundamental research and translational endeavours. In particular, there has recently been a renewed interest in body composition and metabolism in SMA patients, specifically that of fatty acids. Indeed, there is increasing evidence of aberrant fat distribution and fatty acid metabolism dysfunction in SMA patients and animal models. This review will explore fatty acid metabolic defects in SMA and discuss how dietary interventions could potentially be used to modulate and reduce the adverse health impacts of these perturbations in SMA patients.

Identifiants

pubmed: 33498293
pii: brainsci11020131
doi: 10.3390/brainsci11020131
pmc: PMC7909254
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Biol Chem. 2006 May 12;281(19):13180-7
pubmed: 16547005
J Pediatr. 2015 Dec;167(6):1362-8.e1
pubmed: 26454573
Nutr Metab (Lond). 2010 Apr 16;7:30
pubmed: 20398344
Annu Rev Nutr. 2017 Aug 21;37:51-76
pubmed: 28826372
Orphanet J Rare Dis. 2011 Nov 02;6:71
pubmed: 22047105
Neuromuscul Disord. 2018 Feb;28(2):103-115
pubmed: 29290580
J Child Neurol. 2007 Aug;22(8):926-45
pubmed: 17761647
Am J Hum Genet. 2006 Jan;78(1):63-77
pubmed: 16385450
Eur J Biochem. 2003 Apr;270(8):1619-27
pubmed: 12694175
Curr Genomics. 2018 Aug;19(5):339-355
pubmed: 30065610
Pediatr Res. 1999 Oct;46(4):440-4
pubmed: 10509365
Adv Drug Deliv Rev. 2020;159:198-213
pubmed: 31987838
EBioMedicine. 2018 May;31:226-242
pubmed: 29735415
Trends Neurosci. 2021 Jan 7;:
pubmed: 33423791
Clin Nutr. 2017 Dec;36(6):1674-1680
pubmed: 27890489
J Child Neurol. 2014 Nov;29(11):1467-72
pubmed: 24097849
Biochem Biophys Res Commun. 2010 Jan 1;391(1):835-40
pubmed: 19945425
Front Cell Dev Biol. 2016 Jan 28;3:83
pubmed: 26858947
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11159-64
pubmed: 15263088
Curr Opin Lipidol. 2010 Jun;21(3):212-7
pubmed: 20480548
Neuromuscul Disord. 2009 Jun;19(6):391-6
pubmed: 19427208
Ther Adv Neurol Disord. 2010 May;3(3):173-85
pubmed: 21179609
Lancet. 2008 Jun 21;371(9630):2120-33
pubmed: 18572081
Skelet Muscle. 2013 Oct 11;3(1):24
pubmed: 24119341
Mol Cell. 2019 Apr 4;74(1):45-58.e7
pubmed: 30846317
Neuromuscul Disord. 2016 Jul;26(7):395-404
pubmed: 27241822
Cell. 2017 Dec 14;171(7):1545-1558.e18
pubmed: 29153836
Nat Rev Neurosci. 2009 Aug;10(8):597-609
pubmed: 19584893
Sci Rep. 2018 Mar 2;8(1):3953
pubmed: 29500423
Pediatr Neurol. 1995 Jan;12(1):21-30
pubmed: 7748356
Annu Rev Physiol. 2016;78:23-44
pubmed: 26474213
Cell. 1995 Jan 13;80(1):155-65
pubmed: 7813012
Brain. 2018 Aug 1;141(8):2343-2361
pubmed: 29961886
Cell Rep. 2020 Oct 27;33(4):108323
pubmed: 33113361
Am J Med Genet A. 2004 Oct 15;130A(3):307-10
pubmed: 15378550
J Pediatr. 2014 May;164(5):1228-30
pubmed: 24423433
Future Lipidol. 2007 Aug;2(4):465-476
pubmed: 20354580
Hum Mol Genet. 2018 Oct 15;27(20):3582-3597
pubmed: 29982483
Front Neurosci. 2017 Jan 10;10:611
pubmed: 28119559
Brain Commun. 2020 Sep 24;2(2):fcaa154
pubmed: 33241210
Lancet. 2014 Jun 14;383(9934):2065-2072
pubmed: 24582471
Sci Rep. 2019 Aug 12;9(1):11642
pubmed: 31406145
Hum Mol Genet. 2000 Feb 12;9(3):333-9
pubmed: 10655541
Hum Genet. 2012 Aug;131(8):1277-93
pubmed: 22543872
Neurol Clin. 2015 Nov;33(4):831-46
pubmed: 26515624
J Child Neurol. 2007 Aug;22(8):946-51
pubmed: 17761648
Eur J Pharm Sci. 2019 Jun 15;134:31-59
pubmed: 30974173
BMC Neurol. 2015 Oct 24;15:217
pubmed: 26499462
Ann Neurol. 1986 Dec;20(6):734-6
pubmed: 3813501
J Mol Neurosci. 2007;32(2):120-31
pubmed: 17873296
Am J Clin Nutr. 1998 Mar;67(3 Suppl):519S-526S
pubmed: 9497163
Nat Commun. 2019 Mar 22;10(1):1326
pubmed: 30902980
Am J Hum Genet. 2002 Feb;70(2):358-68
pubmed: 11791208
Scott Med J. 1979 Oct;24(4):291-5
pubmed: 555815
Bioessays. 2003 Dec;25(12):1147-9
pubmed: 14635248
Clin Nutr. 2001 Oct;20(5):393-7
pubmed: 11534933
Am J Gastroenterol. 2013 May;108(5):804-10
pubmed: 23399554
BMC Neurosci. 2006 Apr 03;7:29
pubmed: 16584562
J Endocrinol. 2008 May;197(2):189-204
pubmed: 18434349
Muscle Nerve. 2015 Feb;51(2):157-67
pubmed: 25346245
Science. 2008 Apr 25;320(5875):524-7
pubmed: 18440926
Front Mol Biosci. 2016 Mar 10;3:7
pubmed: 27014701
J Res Med Sci. 2012 Sep;17(9):824-7
pubmed: 23826007
Ann Neurol. 2012 Aug;72(2):256-68
pubmed: 22926856
J Biol Chem. 1999 Aug 13;274(33):23078-84
pubmed: 10438476
Ann Clin Transl Neurol. 2019 Nov;6(11):2340-2346
pubmed: 31608604
PPAR Res. 2015;2015:201625
pubmed: 25815008
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):397-405
pubmed: 23421600
Handb Clin Neurol. 2013;113:1675-88
pubmed: 23622388
Ann Neurol. 2008 Oct;64(4):465-70
pubmed: 18661558
Front Neurol. 2019 Apr 04;10:284
pubmed: 31019485
J Anat. 2014 Jan;224(1):15-28
pubmed: 23876144
Future Med Chem. 2012 Oct;4(16):2067-84
pubmed: 23157239
Int J Endocrinol. 2016;2016:5415767
pubmed: 27293434
Dis Model Mech. 2017 Aug 1;10(8):943-954
pubmed: 28768735
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6307-11
pubmed: 10339583
Eur J Hum Genet. 2012 Jan;20(1):27-32
pubmed: 21811307
Ann Neurol. 1999 Mar;45(3):337-43
pubmed: 10072048
Biochim Biophys Acta Gene Regul Mech. 2017 Mar;1860(3):299-315
pubmed: 28095296
Ann Clin Transl Neurol. 2019 Aug;6(8):1519-1532
pubmed: 31402618
Eur J Med Genet. 2018 Nov;61(11):685-698
pubmed: 29313812
Neuromuscul Disord. 2012 Nov;22(11):966-73
pubmed: 22832342
Br J Clin Pharmacol. 2013 Mar;75(3):588-602
pubmed: 22897361
Lancet. 1990 Sep 8;336(8715):629-30
pubmed: 1975398
Pediatr Neurol. 2016 Apr;57:80-3
pubmed: 26803333
Semin Pediatr Neurol. 2008 Sep;15(3):140-9
pubmed: 18708005
Lancet. 1980 Nov 15;2(8203):1088-9
pubmed: 6107716
Ann Hum Genet. 2013 Sep;77(5):435-63
pubmed: 23879295

Auteurs

Katherine S Watson (KS)

Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK.

Imane Boukhloufi (I)

School of Medicine, Keele University, Staffordshire ST5 5BG, UK.

Melissa Bowerman (M)

School of Medicine, Keele University, Staffordshire ST5 5BG, UK.
Wolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry SY10 7AG, UK.

Simon H Parson (SH)

Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK.
Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh EH16 4SB, UK.

Classifications MeSH